- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Pharmaceutical and Medical Device
Events 45 results
Webinar
July 28, 2022
The Drug Supply Chain Security Act – Are Your Operations Ready for Final Implementation?
Speaking Engagement
June 14, 2022
Geneviève Michaux to Speak at Global Biologics Cell and Gene Legal Conference
Speaking Engagement
June 2, 2022
Abby Parsons, Ellen Min to Speak at Rocky Mountain Intellectual Property & Technology Law Institute
Webinar
February 24, 2022
Navigating the Future: Considerations Related to “Femtech” and Other Digital Health Tools
Webinar
January 25, 2022
2021 Year in Review for Drug and Device Advertising and Promotion – Lessons Learned From FDA Enforcement Letters and Other Key Developments
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Webinar
October 29, 2021
Nitrosamines and Beyond: The Future of Regulatory Actions and Litigation in a World of Contamination Claims
Speaking Engagement
October 12, 2021
Heather Bañuelos to Speak at Food and Drug Law Institute’s Introduction to Advertising and Promotion for Medical Products Conference
Speaking Engagement
October 11, 2021
Liz Lindquist to Speak at Informa Connect’s Medicaid Drug Rebate Program Conference
Speaking Engagement
October 8, 2021
Bobby Woo, Geoff Drake to Speak at Atlanta Bar Association’s Litigation Section Breakfast Meeting
Webinar
September 30, 2021
Emerging Trends Regarding EPA’s Regulations Affecting Products: What Life Sciences Companies Should Know
Speaking Engagement
September 14, 2021
Heather Bañuelos to Speak at RAPS Convergence 2021